Artia Global Partners LP Portfolio Holdings

Artia Global Partners LP

  • $367 Billion
  • Q3 2024

Artia Global Partners LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $367 Billion distributed in 45 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Novo Nordisk A S with a value of $88.3B, Eli Lilly & CO with a value of $82B, Viking Therapeutics, Inc. with a value of $33.7B, Intra Cellular Therapies, Inc. with a value of $15.8B, and Astrazeneca PLC with a value of $14.9B.

Examining the 13F form we can see an decrease of $150B in the current position value, from $517B to 367B.

Artia Global Partners LP is based out at Miami, FL

Below you can find more details about Artia Global Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $367 Billion
Healthcare: $350 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$192B
$88.3 Billion 24.07% of portfolio
741,743
Q3 2024 Added 7.23%
$730B
$82 Billion 22.36% of portfolio
92,593
Q4 2023 Added 253.5%
$3.24B
$33.7 Billion 9.2% of portfolio
532,879
Q3 2024 Added 17.64%
$7.88B
$15.8 Billion 4.32% of portfolio
216,519
Q2 2024 Added 3.06%
$203B
$14.9 Billion 4.05% of portfolio
190,752
Q2 2023 Added 86.45%
Soleno Therapeutics Inc
-
$13.9 Billion 3.78% of portfolio
-
Q3 2024 Added 190.63%
$30.2B
$9.63 Billion 2.62% of portfolio
35,000
Q2 2024 New
$102B
$8.79 Billion 2.4% of portfolio
18,900
Q2 2024 Reduced 34.6%
$5.13B
$8.71 Billion 2.38% of portfolio
76,255
Q1 2024 Added 97.78%
$34.5B
$8.21 Billion 2.24% of portfolio
15,138
Q2 2024 Reduced 55.79%
$3.89B
$7.89 Billion 2.15% of portfolio
87,848
Q2 2023 New
$2.04B
$5.6 Billion 1.53% of portfolio
124,440
Q1 2024 Added 10.77%
$13B
$5.18 Billion 1.41% of portfolio
45,000
Q4 2022 New
$3.86B
$4.35 Billion 1.19% of portfolio
95,885
Q3 2024 New
$1.24B
$4.29 Billion 1.17% of portfolio
119,488
Q1 2024 New
$2.56B
$4.27 Billion 1.17% of portfolio
148,590
Q3 2024 Added 13.61%
$9.54B
$3.86 Billion 1.05% of portfolio
52,939
Q3 2024 Reduced 0.93%
$1.18B
$2.56 Billion 0.7% of portfolio
75,300
Q2 2024 New
$2.88B
$2.34 Billion 0.64% of portfolio
45,765
Q3 2024 Reduced 46.64%
$1.23B
$2 Billion 0.54% of portfolio
62,992
Q3 2024 Added 15.81%
$2.22B
$1.73 Billion 0.47% of portfolio
53,930
Q1 2024 New
$419M
$1.73 Billion 0.47% of portfolio
421,359
Q1 2024 New
$3.62B
$1.58 Billion 0.43% of portfolio
15,437
Q3 2024 New
$2.41B
$1.57 Billion 0.43% of portfolio
40,000
Q1 2024 New
$1.62B
$1.29 Billion 0.35% of portfolio
80,380
Q3 2024 New
$9.45B
$1.24 Billion 0.34% of portfolio
6,305
Q3 2024 Reduced 8.69%
$242M
$1.25 Billion 0.34% of portfolio
156,300
Q3 2024 Added 53.99%
$5.06B
$1.22 Billion 0.33% of portfolio
30,479
Q3 2024 Reduced 51.22%
$439M
$1.16 Billion 0.32% of portfolio
20,000
Q2 2024 New
$603M
$1.12 Billion 0.3% of portfolio
57,178
Q2 2024 Added 44.84%
$7.61B
$1.11 Billion 0.3% of portfolio
7,440
Q2 2024 Reduced 53.19%
$249M
$1.02 Billion 0.28% of portfolio
172,226
Q3 2024 Added 16.78%
Corbus Pharmaceuticals Hldgs
-
$978 Million 0.27% of portfolio
-
Q3 2024 Added 137.0%
$247M
$954 Million 0.26% of portfolio
52,476
Q1 2024 New
$154M
$901 Million 0.25% of portfolio
193,317
Q3 2024 New
$740M
$929 Million 0.25% of portfolio
48,263
Q2 2024 New
-
$901 Million 0.25% of portfolio
-
Q1 2024 New
Disc Medicine Inc
-
$660 Million 0.18% of portfolio
-
Q2 2024 Reduced 84.56%
$174M
$593 Million 0.16% of portfolio
90,490
Q2 2024 Added 55.51%
Acelyrin Inc
-
$459 Million 0.13% of portfolio
-
Q3 2024 New
$3.6B
$318 Million 0.09% of portfolio
14,512
Q3 2024 New
$5.28B
$330 Million 0.09% of portfolio
1,557
Q1 2024 New
Q32 Bio Inc
-
$210 Million 0.06% of portfolio
-
Q3 2024 New

Summary

  • Portfolio
  • No. of Stocks 45
  • Current Value $367 Billion
  • Prior Value $517 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 7 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Artia Global Partners LP Portfolio

Follow Artia Global Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Artia Global Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email